Report DMCA Pioglitazone modulates doxorubicin resistance in a in vivo model of drug resistant osteosarcoma xenograft
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.